Table of contents

Expand All Topics

Posttraumatic stress disorder

Background

Overview

Definition
PTSD is a mental disorder resulting from exposure to a traumatic experience, which is typically characterized by intrusive, involuntary, and/or distressing recollection or re-experience of the traumatic events.
1
Pathophysiology
PTSD is caused by traumatic exposure to death, injury, sexual assault, torture, or bodily disfigurement.
2
Epidemiology
In the US, the estimated prevalence of PTSD, based on the Same Event definition of DSM-V for lifetime, past 12 months, and past 6 months, is 8.3%, 4.7%, and 3.8%, respectively.
3
Disease course
The psychological impact of trauma leads to abnormalities in fear learning, threat detection, executive function, emotion regulation, and contextual processing. These neuroendocrine changes are linked to altered activity in the amygdala. PTSD is associated with mood, anxiety, substance abuse disorders, or suicidal ideation leading to serious disability, medical illness, and premature death. The relative risk of suicidal ideation in PTSD is similar to the relative risk of generalized anxiety disorder or alcohol dependence; however, is lower than that of depression.
2

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of posttraumatic stress disorder are prepared by our editorial team based on guidelines from the American Psychological Association (APA 2025), the Canadian Expert Group on Cannabinoids Use in Chronic Pain (CCP-CEG 2023), the United States Department of Defense (DoD/VA 2023), the World Health Organization (WHO 2023), the Ontario Neurotrauma Foundation (ONF ...
Show more

Screening and diagnosis

Indications for screening: as per DoD/VA 2023 guidelines, consider using the Primary Care PTSD Screen for DSM-5 for screening for PTSD.
C
Create free account

More topics in this section

  • Diagnosis

Medical management

General principles
As per DoD/VA 2023 guidelines:
Offer individual psychotherapy over pharmacologic interventions for the treatment of PTSD.
A
Avoid precluding psychotherapies from the treatment of PTSD in patients with comorbid substance use disorder and/or other disorders.
D

More topics in this section

  • Antidepressants

  • Antipsychotics

  • Anticonvulsants

  • Alpha-blockers

  • Other medications

  • Combination therapy

Nonpharmacologic interventions

Psychotherapy
As per APA 2025 guidelines:
Offer the following psychological interventions in patients with PTSD:
cgnitive processing therapy
prolonged exposure
trauma-focused CBT
A
Consider offering the following psychological interventions in patients with PTSD:
cognitive therapy
eye movement desensitization and reprocessing
narrative exposure therapy
C

More topics in this section

  • Technology-based interventions

  • Alternative and complementary therapies

Therapeutic procedures

Therapies with no evidence for benefit: as per DoD/VA 2023 guidelines, avoid offering electroconvulsive therapy or vagus nerve stimulation for the treatment of PTSD.
D
Show 2 more

Specific circumstances

Patients with substance use disorder: as per APA 2025 guidelines, offer the following trauma-focused treatments plus usual treatment for substance use disorder in patients with PTSD and comorbid substance use disorder:
trauma-focused CBT (concurrent treatment of PTSD and substance use)
disorders using prolonged exposure (prolonged exposure plus usual treatment for substance use disorder, trauma-focused CBT plus usual treatment for substance use disorder).
A

More topics in this section

  • Patients after traumatic brain injury

Preventative measures

Prevention after acute stress: as per DoD/VA 2023 guidelines, insufficient evidence to recommend for or against psychotherapy or pharmacotherapy in the immediate post-trauma period to prevent PTSD in persons exposed to trauma.
I
Show 2 more

Follow-up and surveillance

Assessment of treatment response: as per DoD/VA 2023 guidelines, consider using a validated instrument, such as the PTSD Checklist for DSM-5, or a structured clinician-administered interview, such as the Clinician-Administered PTSD Scale, to detect changes in symptom severity over time.
C